Histological criteria for grading of atypia in melanocytic conjunctival lesions

Pathology

Volumn 40, Issue 7, 2008, Pages 676-681

  Maly, Alexander ^a   Epstein, David ^b   Meir, Karen ^a   Pe'er, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Conjunctiva; IJCN; Melanocytic lesion; Melanoma; PAM

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CONJUNCTIVA DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMED JUVENILE CONJUNCTIVAL NAEVI; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC CONJUNCTIVAL LESION; MELANOMA; PRIMARY ACQUIRED MELANOSIS; PROGNOSIS; RECURRENT DISEASE; SCORING SYSTEM;

EID: 55549100255     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802436428     Document Type: Article

References (30)

1. Shields CL, Hakan D, Karatza E, et al. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004; 111: 1747-54.
2. Eng AM, Rosner M. Conjunctival melanomas. Int J Dermatol 1995; 34: 349-53.
3. Folberg R, Jakobiec FA, Bernardino VB, et al. Benign conjunctival melanocytic lesions: clinicopathologic features. Ophthalmology 1989; 96: 436-61.
4. Guillen FJ, Albert DM, Mihm MC Jr. Pigmented melanocytic lesions of the conjunctiva - a new approach to their classification. Pathology 1985; 17: 275-80.
5. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985; 16: 129-35.
6. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998; 42: 321-50.
7. Baum TD, Adamis AP, Jakobiec FA. Primary acquired melanosis of the conjunctiva. Int Ophthalmol Clin 1997; 37: 61-72.
8. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989; 96: 147-66.
9. Zamir E, Mechoulam H, Micera A, et al. Inflamed juvenile conjunctival naevus: Clinicopathological characterisation. Br J Ophthalmol 2002; 86: 28-30.
10. Gloor P, Alexandrakis G. Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci 1995; 36: 1721-9.
11. McLean IW. Differential diagnosis of conjunctival melanoses. Ann Diagn Pathol 1998; 2: 264-70.
12. Folberg R, Jakobiec FA, McLean IW, et al. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol 1992; 5: 2-5.
13. Liesegang TJ, Campbell RJ. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol 1980; 98: 1385-9.
14. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984; 91: 673-8.
15. McDonnell JM, Carpenter JD, Jacobs P, et al. Conjunctival melanocytic lesions in children. Ophthalmology 1989; 96: 986-93.
16. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497-507.
17. Shields JA, Shields CL, editors. Atlas of Conjunctival and Eyelid Tumors. Philadelphia: Lippincott Williams and Wilkins, 1999; 243-65.
18. Folberg R, Baron J, Reeves RD, et al. Animal model of conjunctival primary acquired melanosis. Ophthalmology 1989; 96: 1006-13.
19. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol 1985; 16: 136-43.
20. Levi-Schaffer F, Micera A, Zamir E, et al. Nerve growth gactor and eosinophils in inflamed juvenile conjunctival nevus. Invest Ophthalmol Vis Sci 2002; 43: 1850-6.
21. Massi G, LeBoit PE, editors. Histology of Nevi and Melanoma. Berlin: Springer Verlag, 2004; 337-46.
22. Kornstein MJ, Brooks JS, Eider DE. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res 1983; 43: 2749-53.
23. Sugiura M, Colby KA, Mihm MC Jr, et al. Conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases. Am J Surg Pathol 2007; 31: 185-92.
24. Li H, Yeatts P, Sangueza OP. Malignant melanoma arising from PAM without atypia. Am J Dermatopathol 2006; 28: 232.
25. Talve LA, Collan YU, Ekfors TO. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 1996; 23: 335-43.
26. Sparrow LE, English DR, Taran JM, et al. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 1998; 20: 12-6.
27. Sharara NA, Alexander RA, Luthert PJ, et al. Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology 2001; 39: 426-31.
28. Chowers I, Livni N, Solomon A, et al. MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia. Br J Ophthalmol 1998; 82: 1316-9.
29. Lazzaro B, Elder DE, Rebers A, et al. Immunophenotyping of compound and Spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. J Invest Dermatol 1993; 100: 313-7S.
30. Orchard G. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail. Br J Biomed Sci 2002; 59: 196-20